K233253

Substantially Equivalent

eCARTv5 Clinical Deterioration Suite (eCART)

Applicant: Agilemd, Inc.
Product code: QNL
Advisory panel: Cardiovascular
Date received: 2023-09-28
Decision date: 2024-06-21
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Francisco, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.